Hydroxyurea (NSC-32065) in biologic fluids: dose-concentration relationship.

Suppr

超能文献

作者信息

Beckloff G L, Lerner H J, Frost D, Russo-Alesi F M, Gitomer S

出版信息

Cancer Chemother Rep. 1965 Oct;48:57-8.

PMID:5834739

Abstract

摘要

相似文献

Hydroxyurea (NSC-32065) in biologic fluids: dose-concentration relationship.

Cancer Chemother Rep. 1965 Oct;48:57-8.

Preventive measures against metastases and local recurrence in cancer surgery.

Proc Natl Cancer Conf. 1970;6:19-31.

Cyclophosphamide. Evaluation in recurrent and progressive ovarian cancer.

Am J Obstet Gynecol. 1967 Mar 1;97(5):656-65.

Role of Drug Anesthesia and Cancer.

Drug Res (Stuttg). 2018 Mar;68(3):125-131. doi: 10.1055/s-0043-119071. Epub 2017 Nov 21.

[The principle of chemotherapy in relapse and metastatic breast cancer].

Zhonghua Yi Xue Za Zhi. 2011 Jan 11;91(2):73-5.

Platelet aggregation inhibitors and cancer metastasis.

Ann Chir Gynaecol. 1982;71(3):142-50.

Head and neck cancer.

N Engl J Med. 2001 Dec 27;345(26):1890-900. doi: 10.1056/NEJMra001375.

Haematoxylon dissolved in dimethylsulfoxide used in recurrent neoplasms.

Int Surg. 1968 Jun;49(6):516-27.

Cisplatin-based treatment of adrenocortical carcinoma.

Cancer Treat Rep. 1987 Feb;71(2):222-4.

[Clinical experiences with alkylating substances in the treatment of malignant primary and secondary skeletal tumors].

Zentralbl Chir. 1966 Aug 13;91(33):1197-204.

引用本文的文献

Studies on Synergism in Combinations of Anti-Tumour Agents in Chick Embryos.

Wilhelm Roux Arch Entwickl Mech Org. 1971 Dec;167(4):353-359. doi: 10.1007/BF00580169.

Nucleotide metabolism, oncogene-induced senescence and cancer.

Cancer Lett. 2015 Jan 28;356(2 Pt A):204-10. doi: 10.1016/j.canlet.2014.01.017. Epub 2014 Jan 29.

Interference in DNA replication can cause mitotic chromosomal breakage unassociated with double-strand breaks.

PLoS One. 2013;8(4):e60043. doi: 10.1371/journal.pone.0060043. Epub 2013 Apr 3.

Neuroprotective activity of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (PAN-811), a cancer therapeutic agent.

CNS Drug Rev. 2006 Spring;12(1):77-90. doi: 10.1111/j.1527-3458.2006.00077.x.

Pharmacokinetics and pharmacodynamics of hydroxyurea.

Clin Pharmacokinet. 1998 May;34(5):347-58. doi: 10.2165/00003088-199834050-00002.

Pilot study of 6 weeks of chemoradiotherapy with 5 FU and hydroxyurea in malignant gliomas.

J Neurooncol. 1993 Jan;15(1):9-17. doi: 10.1007/BF01050257.

Population pharmacokinetics of hydroxyurea in cancer patients.

Cancer Chemother Pharmacol. 1995;35(5):417-22. doi: 10.1007/s002800050256.

Cisplatin preceded by concurrent cytarabine and hydroxyurea: a pilot study based on an in vitro model.

Cancer Chemother Pharmacol. 1990;27(1):33-40. doi: 10.1007/BF00689273.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验